Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India

PLoS ONE - United States
doi 10.1371/journal.pone.0068869
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Outcomes of Multidrug-Resistant Tuberculosis Treatment With Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho

PLoS ONE
Multidisciplinary
2012English

Predictors of Unfavourable Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis in India

Public Health Action
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2009English

Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Surgical Interventions for Pulmonary Tuberculosis in Mumbai, India: Surgical Outcomes and Programmatic Challenges

Public Health Action
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

Reply to Anthony Et Al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy